5/29
07:59 am
vrpx
Virpax® Pharmaceuticals to Present at 2024 BIO International Convention [Yahoo! Finance]
Low
Report
Virpax® Pharmaceuticals to Present at 2024 BIO International Convention [Yahoo! Finance]
5/29
07:30 am
vrpx
Virpax® Pharmaceuticals to Present at 2024 BIO International Convention
Low
Report
Virpax® Pharmaceuticals to Present at 2024 BIO International Convention
5/22
12:34 pm
vrpx
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) had its "hold" rating re-affirmed by analysts at Maxim Group.
Neutral
Report
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) had its "hold" rating re-affirmed by analysts at Maxim Group.
5/15
08:20 am
vrpx
Virpax Announces Pricing of $2.25 Million Public Offering [Yahoo! Finance]
High
Report
Virpax Announces Pricing of $2.25 Million Public Offering [Yahoo! Finance]
5/15
08:00 am
vrpx
Virpax Announces Pricing of $2.25 Million Public Offering
High
Report
Virpax Announces Pricing of $2.25 Million Public Offering
5/13
04:23 pm
vrpx
Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments [Yahoo! Finance]
High
Report
Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments [Yahoo! Finance]
5/13
04:10 pm
vrpx
Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments
High
Report
Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments
4/30
07:30 am
vrpx
Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
Medium
Report
Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
3/26
07:42 am
vrpx
Virpax Pharmaceuticals Reports 2023 Year-End Results [Yahoo! Finance]
Medium
Report
Virpax Pharmaceuticals Reports 2023 Year-End Results [Yahoo! Finance]
3/26
07:30 am
vrpx
Virpax Pharmaceuticals Reports 2023 Year-End Results
Medium
Report
Virpax Pharmaceuticals Reports 2023 Year-End Results